Structures targeted by the immune system in myositis

Current Opinion in Rheumatology

Volumn 8, Issue 6, 1996, Pages 521-527

  Mimori, Tsuneyo ^a  

^a KEIO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID TRANSFER RNA LIGASE; AUTOANTIBODY;

ANTIBODY DETECTION; ANTIGEN DETECTION; AUTOIMMUNITY; DERMATOMYOSITIS; HUMAN; IMMUNOPATHOGENESIS; POLYMYOSITIS; PRIORITY JOURNAL; REVIEW;

AMINO ACYL-TRNA SYNTHETASES; ANNEXINS; ANTIGENS, NUCLEAR; AUTOANTIBODIES; CALCIUM-BINDING PROTEINS; DNA HELICASES; DNA-BINDING PROTEINS; EXORIBONUCLEASES; HUMANS; MYOSITIS; NUCLEAR PROTEINS; SIGNAL RECOGNITION PARTICLE;

EID: 0030497505     PISSN: 10408711     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002281-199611000-00005     Document Type: Review

References (69)

1. Gelpi C, Kanterewicz E, Gratacos J, Targoff IN, Rodriguez-Sanchez JL: Coexisting of two antisynthetases in a patient with the antisynthetase syndrome. Arthritis Rheum 1996, 39:692-697.
2. Nishikai M, Reichlin M: Heterogeneity of precipitating antibodies in polymyositis and dermatomyositis: characterization of the Jo-1 antibody system. Arthritis Rheum 1980, 23:881-888.
3. Hirakata M, Mimori T, Akizuki M Craft J, Hardin JA, Homma M: Autoantibodies to small nuclear and cytoplasmic ribonucleoproteins in Japanese patients with inflammatory muscle disease. Arthritis Rheum 1992, 35:449-456.
4. his-containing antigen is recognized by the polymyositis-specific antibody anti-Jo-1. Nucleic Acid Res 1983, 11:853-870.
5. Mathews MB, Bernstein RM: Myositis autoantibody inhibits histidyl-tRNA synthetase: a model for autoimmunity. Nature 1983, 304:177-179.
6. Yoshida S, Akizuki M, Mimori T, Yamagata H, Inada S, Homma M: The precipitating antibody to an acidic nuclear protein antigen, the Jo-1, in connective tissue diseases: a marker for a subset of polymyositis with interstitial pulmonary fibrosis. Arthritis Rheum 1983, 26:604-611.
7. Oddis CV, Medsger TA Jr, Cooperstein LA: A subluxing arthropathy associated with the anti-Jo-1 antibody in polymyositis/dermatomyositis. Arthritis Rheum 1990, 33:1640-1645.
8. Jenkins EA, Hull RG, Thomas AL: D-penicillamine and polymyositis: the significance of the anti-Jo-1 antibody. Br J Rheumatol 1993, 32:1109-1110.
9. Weidensaul D, Imam T, Holyst M-M, King PD, McMurray RW: Polymyositis, pulmonary fibrosis, and hepatitis C. Arthritis Rheum 1995, 38:437-439. This paper describes a new association involving a patient with hepatitis C virus infection and anti-Jo-1-positive polymyositis with interstitial lung disease.
10. Gelpi C, Martinez MA, Vidal S, Targoff IN, Rodriguez-Sanchez JL: Autoantibodies to a transfer RNA-associated protein in a murine model of chronic graft versus host disease. J Immunol 1994, 152:1989-1999.
11. Rotz PH, Rider LG, Targoff IN, Raben N, et al.: Myositis: immunologic contributions to understanding cause, pathogenesis, and therapy. Ann Intern Med 1995, 122:715-724.
12. Targoff IN, Arnett FC, Reichlin M: Antibody to threonyl-transfer RNA synthetase in myositis sera. Arthritis Rheum 1988, 31:515-524.
13. Ala coexist and are associated with myositis. J Exp Med 1986, 163:1281-1291.
14. Targoff IN, Amett FC: Clinical manifestations in patients with antibody to PL-12 antigen (alanyl-tRNA synthetase). Am J Med 1990, 88:241-251.
15. Hirakata M, Nakamura K, Okano Y, Suwa A, Inada S, Akizuki M, Hardin JA: Anti-alanyl tRNA synthetase (PL-12) antibodies are associated with interstitial lung diseases in Japanese patients [abstract]. Arthritis Rheum 1995, 38:8321.
16. Mathews MB, Reichlin M, Hughes GRV, Bernstein RM: Anti-threonyl-tRNA synthetase, a second myositis-related autoantibody. J Exp Med 1984, 160:420-434.
17. Targoff IN, Trieu EP, Miller FW: Reaction of anti-OJ autoantibodies with components of the multi-enzyme complex of aminoacyl-tRNA synthetases in addition to isoleucyl-tRNA synthetase. J Clin Invest 1993, 91:2556-2564.
18. Targoff IN, Trieu EP, Plotz PH, Miller FW: Antibodies to glycyl-transfer RNA synthetase in patients with myositis and interstitial lung disease. Arthritis Rheum 1992, 35:821-830.
19. Hirakata M, Suwa A, Takeda Y, Matsuoka Y, Irimajiri S, Targoff IN, Hardin JA, Craft J: Autoantibodies to glycyl-transfer RNA synthetase in myositis: association with dermatomyositis and immunologic heterogeneity. Arthritis Rheum 1996, 39:146-150. Immunologic heterogeneity of anti-EJ (glycyl-tRNA synthetase) antibodies is described. One patient serum sample with anti-EJ antibodies immunoprecipitated a 75-kD protein along with only one of four associated tRNAs, and this serum sample lacked inhibition of glycylation for the cognate tRNA, suggesting different epitope specificities among anti-EJ sera.
20. Targoff IN, Johnson AE, Miller FW: Antibody to signal recognition particle in polymyositis. Arthritis Rheum 1990, 33:1361-1370.
21. Hirakata M, Nakamura K, Fujii T, Okano Y, Mimori T, Takeda Y, Hardin JA, Akizuki M: Clinical and immunogenetic features of anti-SRP autoantibodies in Japanese patients [abstract]. Arthritis Rheum 1995, 38:8321.
22. Miller FW: Myositis-specific autoantibodies: touchstones for understanding the inflammatory myopathies [clinical conference]. JAMA 1993, 270:1846-1849.
23. Targoff IN, Reichlin M: The association between Mi-2 antibodies and dermatomyositis. Arthritis Rheum 1985, 28:796-803.
24. Rider L, Miller FW, Targoff IN, Sherry DD, Samayoa E, Lindahl M, Wener MH, Pachman LM, Plotz PH: A broadened spectrum of juvenile myositis: myositis-specific autoantibodies in children. Arthritis Rheum 1994, 37:1534-1538.
25. Nilasena DS, Trieu EP, Targoff IN: Analysis of the Mi-2 autoantigen of dermatomyositis. Arthritis Rheum 1995, 38:123-128.
26. Seelig HP, Moosbrugger I, Ehrfeld H, Fink T, Renz M, Genth E: The major dermatomyositis-specific Mi-2 autoantigen is a presumed helicase involved in transcriptional activation. Arthritis Rheum 1995, 38:1389-1399. The authors isolated a full-length cDNA encoding the major Mi-2 antigen. This study demonstrated that the Mi-2 antigen was a 218-kD protein encoded on chromosome 12 and that it had a structural similarity to members of the helicase family.
27. Ge Q, Nilasena DS, O'Brien CA, Frank MB, Targoff IN: Molecular analysis of a major antigenic region of the 240-kD protein of Mi-2 autoantigen. J Clin Invest 1995, 96:1730-1737. Another molecular cloning study of the Mi-2 antigen. The sequence of an apparent partial cDNA encoding the 240-kD Mi-2 antigen contained four potential zinc-linger motifs. The authors claim that the 240-kD Mi-2 is a novel protein.
28. Mimori T, Akizuki M, Yamagata H, Inada S, Yoshida S, Homma M: Characterization of a high molecular weight acidic nuclear protein recognized by autoantibodies in sera from patients with polymyositisscleroderma overlap. J Clin Invest 1981, 68:611-620.
29. Reeves WH: Use of monoclonal antibodies for the characterization of novel DNA-binding proteins recognized by human autoimmune sera. J Exp Med 1985, 161:18-39.
30. Francoeur AM, Peebles CL, Gompper PT, Tan EM: Identification of Ki (Ku, p70/p80) autoantibodies and analysis of anti-Ki autoantibody reactivity. J Immunol 1986, 136:1648-1653.
31. Mimori T, Hardin JA, Steitz JA: Characterization of the DNA-binding protein antigen Ku recognized by autoantibodies from patients with rheumatic disorders. J Biol Chem 1986, 261:2274-2278.
32. Mimori T, Hardin JA: Mechanism of interaction between Ku protein and DNA. J Biol Chem 1986, 261:10375-10379.
33. Dvir A, Peterson SR, Knuth MW, Lu H, Dynan WS: Ku autoantigen is the regulatory component of a template-dependent protein kinase that phosphorylates RNA polymerase II. Proc Natl Acad Sci U S A 1992, 89:11920-11924.
34. Gottlieb TM, Jackson SP: The DNA-dependent protein kinase: requirement for DNA ends an association with Ku antigen. Cell 1993, 72:1-20.
35. Suwa A, Hirakata M, Takeda Y, Jesch SA, Mimori T, Hardin JA: DNA-dependent protein kinase (Ku protein-p350 complex) assembles on double-stranded DNA. Proc Natl Acad Sci U S A 1994, 91:6904-6908.
36. Peterson SR, Jesch SA, Chamberlin TN, Dvir A, Rabindran SK, Wu C, Dynan WS: Stimulation of the DNA-dependent protein kinase by RNA polymerase II transcriptional activator proteins. J Biol Chem 1995, 270:1449-1454.
37. Rathmell WK, Chu G: Involvement of the Ku autoantigen In the cellular response to DNA double-strand breaks. Proc Natl Acad Sci U S A 1994, 91:7623-7627.
38. Taccioli GE, Gottlieb TM, Blunt T, Priestley A, Demengeot J, Mizuta R, Lehmann AR, Alt FW, Jackson SP, Jeggo PA: Ku 80: product of the XRCC5 gene and its role in DNA repair and V(D)J recombination. Science 1994, 265:1442-1445.
39. Smider V, Rathmell WK, Lieber MR, Chu G: Restoration of X-ray resistance and V(D)J recombination in mutant cells by Ku cDNA. Science 1994, 266:288-291.
40. Lees-Miller SP, Godbout R, Chan DW, Weinfeld M, Day RS III, Barron GM, Allalunis-Turner J: Absence of p350 subunit of DNA-activated protein kinase from a radiosensitive human cell line. Science 1995, 267:1183-1185. This paper reports that the radiosensitive human malignant glioma cell line is defective in DNA double-strand breaks and fails to express DNA-PKcs, suggesting that DNA-PK activity is involved in DNA repair.
41. Boubnov NV, Hall KT, Wills Z, Lee SE, He DM, Benjamin DM, Pulaski CR, Band H, Reeves W, Hendrickson EA, Weaver DT: Complementation of the ionizing radiation sensitivity, DNA end binding, and V(D)J recombination defects of double-stranded break repair mutants by the p86 Ku autoantigen. Proc Natl Acad Sci U S A 1995, 92:890-894. This paper reports that introduction of the Ku(p86) gene to radiation-sensitive mutant cell lines that have low expression levels of p86 mRNA normalized defective DNA repair and V(D)J recombination, suggesting that the Ku(p86) protein is essential for DNA repair and V(D)J recombination.
42. Kirchgessner CU, Patil CK, Evans JW, Cuomo CA, Fried LM, Carter T, Oettiinger MA, Brown JM: DNA-dependent kinase (p350) as a candidate gene for the murine SCID defect Science 1995, 267:1178-1183. This paper claims that the defect of the gene encoding DNA-PKcs explains the SCID mouse, because protein levels of DNA-PKcs are extremely reduced in cells from the SCID mouse, and because chromosomal fragments expressing DNA-PKcs complement the SCID phenotype.
43. Blunt T, Finnie NJ, Taccioli GE, Smith GCM, Demengeot J, Gottlieb TM, Mizuta R, Varghese AJ, Alt FW, Jeggo PA, Jackson SP: Defective DNA-dependent protein kinase activity is linked to V(D)J recombination and DNA repair defects associated with the murine scid mutation. Cell 1995, 80:813-832. Cells from the SCID mouse and from the V3 mutant hamster lack DNA-PK activity because of defects in DNA-PKcs. Yeast artificial chromosomes containing the DNA-PKcs gene complement the DNA repair and V(D)J recombination deficiencies of these cells.
44. Hartley KS, Gell D, Smith GCM, Zhang H, Divecha N, Connelly MA, Admon A, Lees-Miller SP, Anderson CW, Jackson SP: DNA-dependent protein kinase catalytic subunit: a relative of phosphatidyl-inositol 3-kinase and the ataxia telanglectasia gene product Cell 1995, 82:849-856. Complementary DNA encoding for 460-kD DNA-PKcs was identified. The structure of DNA-PKcs was found to be related to the phosphatidyl inositol-3-kinase family and the product of the ataxia-telangiectasia gene.
45. Suwa A, Hirakata M, Takeda Y, Okano Y, Mimori T, Inada S, Watanabe F, Teraoka H, Dynan WS, Hardin JA: Autoantibodies to DNA-dependent protein kinase: probes for the catalytic subunit J Clin Invest 1996, 97:1417-1421. In this paper, new autoantibodies to the 460-kD DNA-PKcs are described. Anti-DNA-PKcs were found in 10 of 312 patient serum samples and were associated with anti-Ku antibodies.
46. Suwa A, Hirakata M, Takeda Y, Mimori T, Inada S, Akizuki M, Hardin JA: Identification of autoantibodies directed against the 350-kDa catalytic subunit of DNA-dependent protein kinase [abstract]. Arthritis Rheum 1994, 37:5390.
47. Reichlin M, Maddison PJ, Targoff IN, Bunch TW, Arnett FC, Sharp GC, Treadwell E, Tan EM: Antibodies to a nuclear/nucleolar antigen in patients with polymyositis overlap syndrome. J Clin Immunol 1984, 4:40-44.
48. Oddis CV, Okano Y, Rudert WA, Trucco M, Duquesnoy RJ, Medsger TA Jr: Serum autoantibody to the nucleolar autoantigen PM-Sci: clinical and immunogenetic associations. Arthritis Rheum 1992, 35:1211-1217.
49. Marguene C, Bunn CC, Copier J, Bernstein RM, Gilroy JM, Black CM, So AK, Walport MJ: The clinical and immunogenetic features of patients with autoantibodies to the nucleolar antigen PM-Sci. Medicine 1992, 71:327-336.
50. Reimer G, Scheer U, Peters JM, Tan EM: Immunolocalizatlon and partial characterization of a nucleolar autoantigen (PM-Sci) associated with polymyositis/scleroderma overlap syndrome. J Immunol 1986, 137:3802-3808.
51. Gelpi C, Alguero A, Martinez AM, Vidai S, Juarez C, Rodriguez-Sanchez JL: Identification of protein components reactive with anti-PM-Sci autoantibodies. Clin Exp Immunol 1990, 81:59-64.
52. Ge Q, Frank MB, O'Brien CA, Targoff IN: Cloning of a complementary DNA coding for the 100-kD antigenic protein of the PM-Sci autoantigen. J Clin Invest 1992, 90:559-570.
53. Mimori T, Suganuma K, Tanami Y, Nojima T, Matsumura M, Fujii T, Yoshizawa T, Suzuki K, Akizuki M: Autoantibodies to calpastatin (an endogenous inhibitor for calcium-dependent neutral protease, calpain) in systemic rheumatic diseases. Proc Natl Acad Sci U S A 1995, 92:7267-7271. Newly identified autoantibodies to calpastatin are described. Anticalpastatin antibodies were predominantly found in rheumatoid arthritis but were also detected in SLE, scleroderma, and polymyositis and dermatomyositis. IgG from a patient serum with anticalpastatin inhibited the function of calpastatin.
54. Despres N, Talbot G, Plouffe B, Boire G, Menard HA: Detection and expression of a cDNA clone that encodes a polypeptide containing two inhibitory domains of human calpastatin and its recognition by rheumatoid arthritis. J Clin Invest 1995, 95:1891-1896. Autoantibodies to calpastatin are also described independently. Anticalpastatin antibodies were detected exclusively in rheumatoid arthritis patients in this study.
55. Yamamoto S, Shimizu K, Shimizu K, Suzuki K, Nakagawa Y, Yamamuro T: Calcium-dependent cysteine proteinase (calpain) in human arthritic synovial joint Arthritis Rheum 1992, 35:1309-1317.
56. Suzuki K, Shimizu K, Hatamoto T, Nakagawa Y, Murachi T, Yamamuro T: Characterization of proteoglycan degradation by calpain. Biochem J 1992, 285:857-862.
57. Kobayashi Y, Yamamoto K, Saido T, Kawasaki H, Oppenheim JJ, Matsushita K: Identification of calcium-activated neutral protease as a processing enzyme of human interleukin 1 alpha. Proc Natl Acad Sci U S A 1990, 87:5548-5552.
58. Kunimatsu M, Higashiyama S, Sato K, Ohkubo I, Sasaki M: Calcium dependent cysteine proteinase is a precursor of a chemotactic factor for neutrophils. Biochem Biophys Res Comm 1989, 164:875-882.
59. Kishimoto A, Mikawa K, Hashimoto K, Yasuda I, Tanaka S, Tominaga M, Kuroda T, Nishizuka Y: Limited proteolysis of protein kinase C subspecies by calcium-dependent neutral protease (calpain). J Biol Chem 1989, 264:4088-4092.
60. van Venrooij WJ, Wodzig KW, Habets WJ, de Rooij DJ, van de Putte LB: Anti-56K: a novel, frequently occurring autoantibody specificity in connective tissue disease. Clin Exp Rheumatol 1989, 7:277-282.
61. Misaki Y, Pruijn GJM, van der Kemp AWCM, van Venrooij WJ: The 56K autoantigen is identical to human annexin XI. J Biol Chem 1994, 269:4240-4246.
62. Misaki Y, van Venrooij WJ, Pruijn GJM: Prevalence and characteristics of anti-56K/annexin XI autoantibodies in systemic autoimmune diseases. J Rheumatol 1995, 22:97-102.
63. Arad-Dann H, Isenberg D, Shoenfeld Y, Offen D, Sperling J, Sperling R: Autoantibodies against a specific nuclear RNP protein in sera of patients with autoimmune rheumatic disease associated with myositis. J Immunol 1987, 138:2463-2468.
64. Christensen ML, Pachman LM, Schneiderman R, Patel DC, Friedman JM: Prevalence of coxsackie B virus antibodies in patients with juvenile dermatomyositis. Arthritis Rheum 1986, 29:1365-1370.
65. Walker EJ, Jeffrey PD: Polymyositis and molecular mimicry: a mechanism of autoimmunity. Lancet 1986, 1:605-607.
66. Walker EJ, Jeffrey PD: Sequence homology between encephalomyocarditis virus protein VP1 and histidyl-tRNA synthetase supports a hypothesis of molecular mimicry in polymyositis. Med Hypotheses 1988, 25:21-25.
67. Ge Q, Trieu EP, Targoff IN: Primary structure and functional expression of human glycyl-tRNA synthetase, an autoantigen in myositis. J Biol Chem 1994, 269:28790-28797.
68. Fatenejad S, Mamula MJ, Craft J: Role of intermolecular/intrastructural B- and T-cell determinants in the diversification of autoantibodies to ribonucleoprotein particles. Proc Natl Acad Sci U S A 1993, 90:12010-12014.
69. Dong X, Hamilton KJ, Satoh M, Wang J, Reeves WH: Initiation of autoimmunity to the p53 tumor suppressor protein by complexes of p53 and SV40 large T antigen. J Exp Med 1994, 179:1243-1252.